By www.reliableresearchiq.com
Global Rare Disease Drug Market Insights And Forecast To 2031 Story
129
$ 4900
Rare Disease Drug Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Novartis AG Bristol-Myers Squibb Company Celgene Corporation F. Hoffmann-La Roche Ltd. Pfizer, Inc. Sanofi S.A. Alexion Pharmaceuticals, Inc. Eli Lilly and Company Novo Nordisk A/S AstraZeneca Eisai Co., Ltd. Daiichi Sankyo Company Limited Bayer AG GlaxoSmithKline Merck & Co., Inc. Johnson & Johnson Biogen, Inc. Takeda Amgen, Inc. Deciphera Atara Biotherapeutics ProQR